BNP Paribas Financial Markets’s Serina Therapeutics SER Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $12 | Hold |
2
| – | – | ﹤0.01% | 4589 |
|
2025
Q1 | $11 | Hold |
2
| – | – | ﹤0.01% | 4502 |
|
2024
Q4 | $10 | Hold |
2
| – | – | ﹤0.01% | 4508 |
|
2024
Q3 | $13 | Hold |
2
| – | – | ﹤0.01% | 3384 |
|
2024
Q2 | $19 | Hold |
2
| – | – | ﹤0.01% | 3328 |
|
2024
Q1 | $27 | Hold |
2
| – | – | ﹤0.01% | 3323 |
|
2023
Q4 | $28 | Hold |
2
| – | – | ﹤0.01% | 3257 |
|
2023
Q3 | $50 | Hold |
2
| – | – | ﹤0.01% | 3186 |
|
2023
Q2 | $66 | Hold |
2
| – | – | ﹤0.01% | 3244 |
|
2023
Q1 | $49 | Sell |
2
-7
| -78% | -$172 | ﹤0.01% | 3162 |
|
2022
Q4 | $184 | Hold |
9
| – | – | ﹤0.01% | 3263 |
|
2022
Q3 | $188 | Hold |
9
| – | – | ﹤0.01% | 3901 |
|
2022
Q2 | $192 | Sell |
9
-9
| -50% | -$192 | ﹤0.01% | 3355 |
|
2022
Q1 | $541 | Hold |
18
| – | – | ﹤0.01% | 3440 |
|
2021
Q4 | $691 | Hold |
18
| – | – | ﹤0.01% | 3435 |
|
2021
Q3 | $596 | Hold |
18
| – | – | ﹤0.01% | 3315 |
|
2021
Q2 | $983 | Hold |
18
| – | – | ﹤0.01% | 3346 |
|
2021
Q1 | $1.03K | Hold |
18
| – | – | ﹤0.01% | 3352 |
|
2020
Q4 | $964 | Sell |
18
-110
| -86% | -$5.89K | ﹤0.01% | 3365 |
|
2020
Q3 | $3.65K | Sell |
128
-82
| -39% | -$2.34K | ﹤0.01% | 3401 |
|
2020
Q2 | $7K | Sell |
210
-27
| -11% | -$900 | ﹤0.01% | 3237 |
|
2020
Q1 | $7.75K | Buy |
237
+155
| +189% | +$5.07K | ﹤0.01% | 3430 |
|
2019
Q4 | $5.27K | Buy |
82
+19
| +30% | +$1.22K | ﹤0.01% | 3515 |
|
2019
Q3 | $4.34K | Buy |
63
+29
| +85% | +$2K | ﹤0.01% | 3642 |
|
2019
Q2 | $4.44K | Buy |
+34
| New | +$4.44K | ﹤0.01% | 3630 |
|